Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case-Fatality in the Atherosclerosis Risk in Communities Study.

Hurwitz LM, Joshu CE, Barber JR, Prizment AE, Vitolins MZ, Jones MR, Folsom AR, Han M, Platz EA.

Cancer Epidemiol Biomarkers Prev. 2018 Nov 28. pii: cebp.0965.2018. doi: 10.1158/1055-9965.EPI-18-0965. [Epub ahead of print]

PMID:
30487131
2.

Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.

Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ.

Am J Gastroenterol. 2011 Jul;106(7):1340-50. doi: 10.1038/ajg.2011.38. Epub 2011 Mar 15.

3.

Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.

Zhou CK, Daugherty SE, Liao LM, Freedman ND, Abnet CC, Pfeiffer R, Cook MB.

Cancer Prev Res (Phila). 2017 Jul;10(7):410-420. doi: 10.1158/1940-6207.CAPR-17-0033. Epub 2017 May 15.

4.

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.

Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):390-6.

5.

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.

Jacobs EJ, Rodriguez C, Mondul AM, Connell CJ, Henley SJ, Calle EE, Thun MJ.

J Natl Cancer Inst. 2005 Jul 6;97(13):975-80.

PMID:
15998950
6.

Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.

Bardia A, Ebbert JO, Vierkant RA, Limburg PJ, Anderson K, Wang AH, Olson JE, Vachon CM, Cerhan JR.

J Natl Cancer Inst. 2007 Jun 6;99(11):881-9.

PMID:
17551148
7.

Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.

Skriver C, Dehlendorff C, Borre M, Brasso K, Sørensen HT, Hallas J, Larsen SB, Tjønneland A, Friis S.

Cancer Causes Control. 2016 Sep;27(9):1067-79. doi: 10.1007/s10552-016-0785-7. Epub 2016 Aug 9.

PMID:
27503490
8.

Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.

Veitonmäki T, Murtola TJ, Talala K, Taari K, Tammela T, Auvinen A.

PLoS One. 2016 Apr 21;11(4):e0153413. doi: 10.1371/journal.pone.0153413. eCollection 2016.

9.

Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort.

Brasky TM, Velicer CM, Kristal AR, Peters U, Potter JD, White E.

Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3185-8. doi: 10.1158/1055-9965.EPI-10-0942. Epub 2010 Oct 8.

10.

Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.

Liu Y, Chen JQ, Xie L, Wang J, Li T, He Y, Gao Y, Qin X, Li S.

BMC Med. 2014 Mar 28;12:55. doi: 10.1186/1741-7015-12-55. Review.

11.

Aspirin and other nonsteroidal anti-inflammatory drugs and risk of non-hodgkin lymphoma.

Teras LR, Gapstur SM, Patel AV, Thun MJ, Diver WR, Zhai Y, Jacobs EJ.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):422-8. doi: 10.1158/1055-9965.EPI-12-1158. Epub 2013 Jan 17.

12.

Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).

Murad AS, Down L, Davey Smith G, Donovan JL, Athene Lane J, Hamdy FC, Neal DE, Martin RM.

Int J Cancer. 2011 Mar 15;128(6):1442-8. doi: 10.1002/ijc.25465.

13.

Outcomes of Prostate-specific Antigen-based Prostate Cancer Screening Among Men Using Nonsteroidal Anti-inflammatory Drugs.

Murtola TJ, Vettenranta AM, Talala K, Taari K, Stenman UH, Tammela TLJ, Auvinen A.

Eur Urol Focus. 2018 Dec;4(6):851-857. doi: 10.1016/j.euf.2017.03.005. Epub 2017 Mar 24.

PMID:
28753870
14.

Exploring Differences in the Aspirin-Colorectal Cancer Association by Sex and Race/Ethnicity: The Multiethnic Cohort Study.

Park SY, Wilkens LR, Kolonel LN, Monroe KR, Haiman CA, Marchand LL.

Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):162-169. doi: 10.1158/1055-9965.EPI-16-0560. Epub 2016 Oct 10.

15.

Non-aspirin NSAID use and ovarian cancer mortality.

Verdoodt F, Dehlendorff C, Friis S, Kjaer SK.

Gynecol Oncol. 2018 Aug;150(2):331-337. doi: 10.1016/j.ygyno.2018.06.018. Epub 2018 Jun 28.

PMID:
29960709
16.

Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.

Veitonmäki T, Murtola TJ, Määttänen L, Taari K, Stenman UH, Tammela TL, Auvinen A.

Prostate. 2015 Sep;75(13):1394-402. doi: 10.1002/pros.23020. Epub 2015 Jun 12.

PMID:
26073992
17.

Use of Aspirin and NSAIDs to Prevent Colorectal Cancer [Internet].

Rostom A, Dube C, Lewin G.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Mar.

18.

A cohort study investigating aspirin use and survival in men with prostate cancer.

Flahavan EM, Bennett K, Sharp L, Barron TI.

Ann Oncol. 2014 Jan;25(1):154-9. doi: 10.1093/annonc/mdt428.

PMID:
24356627
19.

The use of aspirin and the risk of mortality in patients with prostate cancer.

Assayag J, Pollak MN, Azoulay L.

J Urol. 2015 Apr;193(4):1220-5. doi: 10.1016/j.juro.2014.11.018. Epub 2014 Nov 14.

PMID:
25463991
20.

Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Schenk JM, Calip GS, Tangen CM, Goodman P, Parsons JK, Thompson IM, Kristal AR.

Am J Epidemiol. 2012 Jul 15;176(2):156-63. doi: 10.1093/aje/kwr524. Epub 2012 Jun 28.

Supplemental Content

Support Center